Amalgamated Bank’s Fortress Biotech FBIO Stock Holding History

Amalgamated Bank’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-808	Closed	-$16K	–	3087
2022 Q1	$16K	Sell	808 -58	-7%	-$1.59K	﹤0.01%	2859
2021 Q4	$32K	Sell	866 -7	-0.8%	-$312	﹤0.01%	2130
2021 Q3	$42K	Sell	873 -29	-3%	-$1.42K	﹤0.01%	2139
2021 Q2	$48K	Buy	+902	New	+$54.4K	﹤0.01%	2166

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Amalgamated Bank's FBIO Position: Q2 2022 in Review

Amalgamated Bank sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 808 shares — an estimated $16K sold.

Amalgamated Bank first reported a position in FBIO in Q2 2021 and held it in 4 quarters. The position peaked at $48K in Q2 2021. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

Amalgamated Bank reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 808 Fortress Biotech shares in Q2 2022, an estimated $16K.
Amalgamated Bank first reported a position in Fortress Biotech in Q2 2021 and held it in 4 quarters.
Amalgamated Bank's Fortress Biotech position peaked at $48K in Q2 2021.
66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.